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Loss of Cone Molecular Markers in Rhodopsin-Mutant Human Retinas
with Retinitis Pigmentosa
Abstract
Purpose: To examine the effect of rhodopsin mutations on cone photoreceptors in human retinas with
retinitis pigmentosa (RP).
Methods: Four RP retinas with rhodopsin mutations and four normal retinas were examined by
immunofluorescence with a battery of cell-specific antibodies against cone and rod cytoplasmic and outer
segment membrane proteins. Areas of the retinas were studied that showed maximal preservation of
photoreceptor structure.
Results: All four RP retinas showed loss of rods, ranging from mild (T-17-M), to more severe (P-23-H), to
advanced degeneration (Q-64-ter and G-106-R). The majority of cones in the T-17-M and P-23-H retinas
were cytologically normal but showed loss of immunoreactivity for the cytoplasmic proteins 7G6, calbindin,
and X-arrestin. The cone outer segments (OS) remained positive for cone opsins and peripherin-2 (rds/
peripherin). All remaining cones in the Q-64-ter and G-106-R retinas were degenerate, with short to absent
OS, but had strong reactivity for these cytoplasmic and OS membrane markers. Cones in the maculas of the
RP retinas were degenerate, with short to absent OS, but retained strong labeling for the cytoplasmic and OS
proteins.
Conclusions: Even before cones show cytologic changes in response to rod cell degeneration, they lose
immunoreactivity for certain cytoplasmic proteins. These cones later show shortening and loss of OS,
although their OS membrane proteins remain well labeled. Cones may down regulate expression of both
cytoplasmic and outer segment membrane proteins in response to mutant rod cell dysfunction and/or cell
death in human RP retinas. Such cytologic and immunocytochemical changes in the cones may presage death
of these critical cells in the later stages of RP.
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Retinitis pigmentosa (RP) is a group of inherited diseases
that causes primary degeneration of rod photoreceptors in the
human retina [1]. The disease is heterogeneous and caused by
mutations in at least 30 different genes (RetNet). The first RP
gene identified was rhodopsin (RHO) [2-6]. More than 80 dif-
ferent RHO mutations are now believed to cause autosomal
dominant (ad) RP [7-9]. The first symptoms of RP, often noted
in adolescence, are night vision disturbances due to rod dys-
function and cell death. Later in the disease, the critical cone
photoreceptors lose function and degenerate, significantly
decreasing the quality of life for the RP patient.
Many gaps remain in our understanding of how RHO mu-
tations lead to primary rod cell death and secondary cone cell
pathology [10,11]. It is unknown why defective and/or dying
rod cells cause eventual loss of cones. This occurs in patients
with RHO mutations as well as in patients with mutations in
other rod-specific genes (e.g., the cGMP-phosphodiesterase
α- and β-subunits [PDE6A, PDE6B] and the cyclic GMP gated
channel protein α subunit [CNGA1]) [12]. It has been hypoth-
esized that dying rods release substances toxic to the adjacent
cones [13], or that cones are dependent on trophic factor(s)
normally derived from the rods [14-18]. Increased informa-
tion on molecular changes in cones in retinas with rod-spe-
cific mutations is essential for understanding the pathophysi-
ology of RP and developing rational therapies for this disease.
To gain insight into the process of rod and cone cell degenera-
tion in RP, we have used immunocytochemistry to evaluate
the retinas of four RP patients with ad RP caused by different
RHO mutations. We report the labeling patterns produced by
a battery of antibodies against cone and rod specific proteins,
and present new evidence on the sequence of molecular
changes occurring in cones that appear structurally normal or
show degenerative changes in RP retinas.
METHODS
Tissue Preparation:  Post mortem adult human eyes were ob-
tained through the donor programs of the Foundation Fight-
ing Blindness (FFB, Hunt Valley, MD) and the University of
Washington Lions Eye Bank (Seattle, WA). The research fol-
lowed the tenets of the Declaration of Helsinki and informed
consent was obtained from all donors ante mortem. The re-
search was approved by the institutional human subjects re-
view board of the University of Pennsylvania. Four RP and
four normal retinas were evaluated (Table 1). All globes were
fixed for several weeks to months in 4% paraformaldehyde,
with or without 0.5% glutaraldehyde, in 0.1 M phosphate
buffer, pH 7.3, and stored thereafter in 2% paraformaldehyde
in the same buffer. The RP retinas had the following rhodop-
sin mutations: threonine-17-methionine (T-17-M; FFB-316
[19]), glutamine-64-ter (Q-64-ter; FFB-424 [20]), proline-23-
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histidine (P-23-H; FFB-360), and glycine-106-arginine (G-
106-R; FFB-517 [10]). Clinical information on three of the
patients has been published [10,19,20]. The fourth patient (P-
23-H mutation; FFB-360) was from a family with ad RP af-
fecting 10 family members in six generations. He had been
night blind since early childhood, lost peripheral vision in his
30’s, and macular vision in his 50’s.
Immunocytochemistry:  Retinal samples were sectioned
with a cryostat at 12 µm and processed for immunofluores-
cence by published techniques [21]. The secondary antibod-
ies (goat anti-rabbit or anti-mouse IgG) were labeled with
Alexa Fluor (green; Molecular Probes, Eugene, OR), Cy-2
(green) or Cy-3 (red; Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA). Nuclei were stained (blue) with DAPI
(1 µg/ml; Molecular Probes). Control sections were treated in
the same way with omission of primary antibody.
Cell specific antibodies prepared in rabbits or mice were
used for immunofluorescence study of the RP and normal
human retinas (Table 2). The immunolabeled retinal sections
were examined with a Leica DMR microscope (Deerfield, IL)
  Case      Age/Gender   PMI (h)   Fixative   Diagnosis
--------   ----------   -------   --------   ---------
FFB-316       68 M        8.25       P        ad RP*
FFB-424       50 F        6.5      P + G      ad RP**
FFB-360       84 M       24.       P + G      ad RP#
FFB-517       99 F        5.25     P + G      ad RP##
FFB-525       65 M        6.0      P + G      Normal
0164-00       75 M        4.25     P + G      Normal
0403-93       51 F        3.0        P        Normal
99-11-23      53 M        0.         P        Normal
PMI = post mortem interval
P = 4% paraformaldehyde
G = 0.5% glutaraldehyde
*rhodopsin thr-17-met mutation
**rhodopsin glu-64-ter mutation
#rhodopsin pro-23-his mutation
##rhodopsin gly-106-arg mutation
TABLE 1. CHARACTERISTICS OF HUMAN RETINAS USED IN STUDY
Normal and RP eyes were fixed and processed by similar methods.
                        Cell            Marker        Specificity       Species   Dilution        Source
                 -------------------   ---------   ------------------   -------   --------   ----------------
                 Cones                 7G6         unknown              mouse     1:250      P. MacLeish
                 Cones                 -           X-arrestin           mouse     1:100      G. Inana
                 Cones                 JH492       red/green            rabbit    1:5,000    J. Nathans
                                                   cone                 opsin
                 Cones                 UW-16       red/green            rabbit    1:200      J. Saari
                                                   cone opsin
                 Cones                 JH455       blue cone opsin      rabbit    1:5,000    J. Nathans
                 Cones                 PNA-        cone sheaths         plant     1:100      Vector Labs
                                       rhodamine                        lectin
                                       (RL1072)
                 Interphotoreceptor    -           interphotoreceptor   rabbit    1:100      J. Saari
                 matrix                            retinoid-binding
                                                   protein
                 Cones and rods        Per         peripherin-2         mouse     1:30       R. Molday
                                       3Bg/5H2
                 Cones, rods           P26         recoverin            rabbit    1:1000     A. Dizhoor
                 bipolar cells
                 Cones,                C8666       calbindin            mouse     1:200      Sigma
                 Horizontal, bipolar
                 and amacrine cells
                 Cones, rods,          A6403       cytochrome C         mouse     1:1000     Molecular Probes
                 inner retinal cells               oxidase
                 Rods                  4D2         rhodopsin            mouse     1:40       R. Molday
                 Rods                  -           rhodopsin            rabbit    1:3000     E. Kean
                 Rods                  A9C6        rod arrestin         mouse     1:1000     L. Donoso
                 (S-antigen)
                 Astrocytes and        ZO334       GFAP                 rabbit    1:750      Dako
                 reactive
                 Müller cells
TABLE 2. CELL-SPECIFIC MARKERS USED IN STUDY
Cell specific antibodies were used to assess cone immunoreactivity in retinas with RHO mutations.
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using epifluorescence and Nomarski differential interference
contrast (DIC) microscopy. The sections were photographed
with Kodak (Rochester, NY) Elite Chrome film, ASA 400.
After each immunofluorescence exposure, the same region was
photographed by Nomarski DIC microscopy. Images were
digitized with a flat bed scanner (Saphir HiRes, Heidelberg
CPS GmbH, Bad Homburg, Germany) using LinoColor Elite
5.1 software (Heidelberg CPS GmbH), imported into a graph-
ics program (PhotoShop 5.0, Adobe, San Jose, CA) and dye-
sublimation prints were generated.
RESULTS
Normal Retinas:  In the normal human retinas, all photore-
ceptors in the macula and periphery showed the expected pat-
terns of labeling with the cell-specific markers used in this
study. All cones had cytoplasmic and outer segment (OS) la-
beling with 7G6 (Figure 1A), and X-arrestin (Figure 1B), and
the cytoplasm of their inner segments, cell bodies and syn-
apses was positive with anti-calbindin (Figure 1C), which also
labeled horizontal cells and some bipolar and amacrine cells.
The cytoplasm and OS of all cones and rods were positive
with anti-recoverin, which also labeled a population of cone
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Figure 1. Immunocytochemi-
cal labeling of normal human
retinas.  A. Antibody 7G6 pro-
duces labeling of the outer
segments and cytoplasm of
the inner segments, cell bod-
ies and synapses of all cone
photoreceptors. B. Anti-X-
arrestin labels the outer seg-
ments and the cytoplasm of
the cell bodies and synapses
of all cones. C. Anti-calbindin
labels the cytoplasm of the
cone inner segments, cell bod-
ies and synapses. The hori-
zontal cells and some bipolar
and amacrine cells are also
labeled. D. The outer seg-
ments and cytoplasm of the
cones and rods are positive
with anti-recoverin. A popu-
lation of cone bipolar cells is
also recoverin-positive. E. All
cones are positive with anti-
body 7G6 (red) and the ma-
jority of cone outer segments
are positive (gold) for red/
green cone opsin. F. All cones
are 7G6-positive (red) and a
few cone outer segments
(gold) are blue cone opsin-
positive. G. The cone and rod
outer segments are positive
with anti-peripherin-2. H. The
rod outer segments are
rhodopsin-positive but the
cones (*) appear as negative
images.
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bipolar cells (Figure 1D). Most cone OS were labeled with
anti-red/green cone opsin (Figure 1E) and the remaining cone
OS were positive for blue cone opsin (Figure 1F). The cone
and rod OS were labeled with anti-peripherin-2 (rds/peripherin,
Figure 1G) and the rod OS were reactive for rhodopsin (Fig-
ure 1H). The cone sheaths were uniform in structure and la-
beled with PNA-rhodamine (Figure 1I) and the
interphotoreceptor matrix (IPM) was positive for IRBP (Fig-
ure 1J). The rod OS were strongly labeled and a few rod cell
bodies and synapses were weakly labeled with anti-rod arrestin
(Figure 1K). Mitochondria in the ellipsoids of cones and rods
were strongly positive for cytochrome C oxidase (Figure 1L).
Mitochondria in the outer and inner plexiform layers, and in
some inner nuclear layer cells, were also labeled with anti-
cytochrome C oxidase (Figure 1L). Immunolabeling with anti-
GFAP was restricted to astrocytes and Müller end feet (Figure
1M). Treatment of the sections with no primary antibody pro-
duced no specific labeling but the retinal pigment epithelium
(RPE) was filled with autofluorescence lipofuscin granules
(Figure 1N).
Threonine-17-Methionine RHO Mutation (FFB-316):  As
reported previously [19], the inferior half of this retina was
severely degenerate and contained no photoreceptors. Samples
for the current study were taken from the superior and nasal
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Figure 1, continued. I. The ex-
tracellular cone sheaths are
uniform in structure and
PNA-positive (red). J. The
inter-photoreceptor matrix is
positive for IRBP (green). All
cones are labeled (red) with
7G6. K. The rod outer seg-
ments are strongly labeled
(red) with anti-rod arrestin.
Some rod cell bodies and syn-
apses are weakly positive. L.
Mitochondria in the cone and
rod inner segments (*) are
positive for cytochrome C
oxidase. The inner and outer
plexiform layers and some
cells in the inner nuclear layer
(n) are also labeled. M. La-
beling with anti-GFAP
(green) is restricted to astro-
cytes and Müller end feet. The
cones are labeled (red) with
7G6. N. Control section
treated with no primary anti-
body shows only auto-fluo-
rescent lipofuscin granules in
the RPE. Autofluorescent li-
pofuscin is present in the reti-
nal pigment epithelium at the
bottom of the panels. The
scale bar represents 50 µm.
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mid and far periphery, which contained both cones and rods,
and the macula, which contained only scattered cones that
lacked OS. When observed by DIC, cones and rods in the su-
perior regions appeared near normal in numbers and cytology
except for some OS shortening, particularly in the rods. The
superior retina retained 40-50% of outer nuclear layer (ONL)
nuclei in the mid periphery and 50-75% of ONL nuclei in the
far periphery.
Approximately 75% of the cones in the superior retina
had marked loss of 7G6 immunoreactivity in their inner seg-
ments, cell bodies and synapses (Figure 2A) even though these
cones were cytologically intact by DIC microscopy (Figure
2B). Cones that had lost 7G6 immunoreactivity could not be
distinguished from neighboring 7G6-positive cones by DIC
(Figure 2B). All cone OS were labeled with anti-peripherin-2,
and most were positive for red/green cone opsin (Figure 2C);
only a few cone OS were labeled with anti-blue cone opsin.
The pattern of labeling with anti-X-arrestin, anti-
recoverin, and anti-calbindin was very similar to that with 7G6.
Many cones had lost OS and cytoplasmic labeling for X-
arrestin (Figure 2D) and double labeling with anti-X-arrestin
and 7G6 showed that the same cones had lost immunoreactiv-
ity for both proteins (Figure 2D-F). Immunoreactivity for
calbindin was also absent in the majority of the cones, although
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Figure 2. Immunocy-
tochemistry of retina with T-
17-M RHO mutation.  A.
7G6 labels some cone outer
and inner segments, cell
bodies and synapses. The
remainder of the cones have
lost 7G6 immunoreactivity
in their inner segments, cell
bodies and synapses. B.
DIC microscopy of the
same field shown in A, il-
lustrating the near normal
cytologic appearance of the
cones (arrowheads). C.
Only a few cones are la-
beled with 7G6 (red) but
most cone outer segments
are labeled with anti-red/
green cone opsin (green).
The cone (*) with a 7G6-
positive but red/green cone
opsin-negative outer seg-
ment is presumably a blue
cone. D. Labeling with anti-
X-arrestin (red) shows that
many cones have lost reac-
tivity for this protein. E.
Double labeling of the field
in D with 7G6 (green) illus-
trates that the same cones
have lost immunoreactivity
for both arrestin and 7G6. F.
Nomarski image of field
shown in D and E. The
cones are indicated by ar-
rowheads.
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the horizontal, bipolar and amacrine cells in the same sections
continued to show strong labeling with anti-calbindin (Figure
2G). The extracellular domains of cones and rods in the IPM
were examined with PNA lectin and anti-IRBP. The cone
matrix sheaths were shortened and weakly PNA-positive. IRBP
in the IPM was very weakly labeled (Figure 2H). In the macula,
the cone matrix sheaths were strongly PNA-positive but very
short (Figure 2I) and IRBP labeling was absent.
The rod OS were shortened but showed normal intensity
of rhodopsin labeling in the superior retina, as observed in the
controls. Rhodopsin labeling was also delocalized to a few
rod cell bodies and synapses (Figure 2J) but no rod neurite
sprouting was observed. Double labeling with 7G6 and anti-
rhodopsin revealed that rods were well labeled with anti-
rhodopsin in the areas where 7G6 cone labeling was mark-
edly reduced. Rod arrestin was strongly labeled in the rod OS,
inner segments, cell bodies and synapses (Figure 2K). This
labeling pattern was different from the control retinas, where
labeling with anti-arrestin was heaviest in the OS (Figure 1K).
Mitochondria in the rod and cone inner segments were well
labeled with anti-cytochrome C oxidase (Figure 2L). Treat-
ment with anti-GFAP produced a few labeled Müller cell pro-
cesses extending from the inner retina to the external limiting
membrane, although no correlation could be found between
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Figure 2, continued. G. Labeling
with anti-calbindin illustrates
loss of reactivity for this protein
in most cones, although the hori-
zontal, bipolar and amacrine cells
continue to show strong labeling
with the antibody. H.
Immunolabeling with anti-IRBP
reveals very weak reactivity for
this protein (green) in the
interphotoreceptor matrix. The
cones are labeled (red) with 7G6.
I. In the macula, the cone matrix
sheaths (red, *) are very short but
strongly PNA-positive. c, mono-
layer of cone nuclei; n, inner
nuclear layer. J. In the periphery,
the rod outer segments are short-
ened but show normal intensity
of labeling with anti-rhodopsin.
One rod (arrowhead) shows cell
body labeling with anti-rhodop-
sin. K. Rod arrestin is localized
in the rod outer and inner seg-
ments, cell bodies and synapses.
L. The rod and cone inner seg-
ments (*) are well labeled for the
mitochondrial protein, cyto-
chrome C oxidase. M. GFAP la-
beling is increased in Müller pro-
cesses in an area where some
cones have lost 7G6 reactivity
and have ectopic nuclei (arrow-
heads) in their inner segments. N.
DIC of field in M illustrating the
cytologic features of the cones
(arrowheads). Autofluorescent li-
pofuscin is present in the retinal
pigment epithelium at the bottom
of the panels. The scale bar rep-
resents 50 µm.
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GFAP-positive Müller processes and abnormalities in the rods
or RPE. GFAP-labeling was increased in Müller processes in
areas where cones had lost 7G6 reactivity and had nuclei dis-
placed into their inner segments (Figure 2M). DIC micros-
copy revealed that near normal numbers of cones were re-
tained in these regions (Figure 2N).
Glutamine-64-ter RHO Mutation (FFB-424): Retinal
samples were taken from the temporal far periphery and the
macula. This retina showed advanced disease and the ONL
was reduced to 1-3 layers of cells in the peripheral region ex-
amined. All photoreceptors had absent or very short outer seg-
ments. All remaining cones, as identified by DIC, were strongly
labeled with 7G6 (Figure 3A), anti-X-arrestin, anti-recoverin
and anti-calbindin. The shortened cone OS were positive for
peripherin-2 and red/green cone opsin (Figure 3B) but not for
blue cone opsin. The cone matrix sheaths were very short and
PNA-positive but IRBP-labeling was absent. The macular
cones were reduced to a single layer of cell bodies that showed
uniformly strong labeling with 7G6 (Figure 3C) and anti-X-
arrestin. The cone OS were tiny but well labeled with 7G6
(Figure 3C), anti-peripherin-2 and anti-red/green cone opsin.
Their matrix sheaths were shortened but strongly PNA-posi-
tive (Figure 3D). Scattered rhodopsin-positive rod cell bodies
were retained in the macula (not shown).
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Figure 3. Immunocytochem-
istry of retina with Q-64-ter
RHO mutation.  A. All re-
maining cones are strongly
labeled with 7G6. Their
outer segments are very
short. B. The shortened cone
outer segments (gold) are
positive for red/green cone
opsin and 7G6 (red). C. The
macular cones are reduced to
a single layer of cell bodies
that are strongly labeled with
7G6. Their outer segments
have formed a layer of 7G6-
positive debris in the
subretinal space. D. The ma-
trix sheaths of the macular
cones are shortened but
strongly PNA-positive (red).
c, cone nuclei; n, inner
nuclear layer. E. As revealed
by labeling with anti-
rhodopsin, the rods have
very short or absent outer
segments and rhodopsin is
delocalized to their cell bod-
ies and long neurites extend-
ing into the inner retina. Ar-
rowhead indicates inner lim-
iting membrane. F. GFAP-
positive Müller processes
(green) are hypertrophied.
Rhodopsin in the rod cell
bodies (r) and neurites is la-
beled red. Autofluorescent
lipofuscin is present in the
retinal pigment epithelium at
the bottom of the panels. The
scale bar represents 50 µm.
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Rods in the peripheral retina had very short OS strongly
reactive for rhodopsin, which was also present in the surface
membranes of the inner segments and cell bodies. Many rods
had rhodopsin-positive neurites extending into the inner retina
as far as the inner limiting membrane (Figure 3E). Labeling
with anti-peripherin-2 was restricted to the shortened rod OS.
Arrestin and recoverin were well labeled in the rod inner seg-
ments and cell bodies. Mitochondria in the rod and cone inner
segments were very weakly reactive for cytochrome C oxi-
dase. Müller cell processes were hypertrophied and strongly
positive for GFAP (Figure 3F).
Proline-23-Histidine RHO Mutation (FFB-360): Retinal
samples were taken from the nasal and temporal mid and far
periphery. Macular samples were not available. The periph-
eral regions showed retention of 1-4 rows of ONL nuclei.
Examination of the peripheral regions by DIC revealed short-
ening and loss of rod and cone OS. Approximately 30% of the
remaining cones had reduced immunoreactivity for 7G6, X-
arrestin and calbindin. The rest of the cones showed normal
labeling with antibodies to these proteins. Most cones were
well labeled with 7G6 (Figure 4A,B). The shortened cone OS
were reactive for peripherin-2 and red/green (Figure 4C) but
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Figure 4. Immunocytochemis-
try of retina with P-23-H RHO
mutation.  A. Most remaining
cones are well labeled with
7G6. B. DIC microscopy of
same field as Figure 4A. The
cones are indicated by the ar-
rowheads. C. Some cones are
well labeled with 7G6 (red)
and most cone outer segments
are positive (gold) for red/
green cone opsin. D. IRBP
immunolabeling (green) is ab-
sent from the interphotorecep-
tor matrix. The cones are 7G6-
positive (red). The retinal pig-
ment epithelium cells are en-
larged and engorged with
autofluorescent (red) lipofus-
cin granules. E. Cytochrome C
oxidase labeling is weak in the
shortened photoreceptor inner
segments (*). F. GFAP label-
ing is strong in the hypertro-
phied Müller cell processes.
Some cones, whose outer seg-
ments are tiny, are 7G6-posi-
tive (red). Autofluorescent li-
pofuscin is present in the reti-
nal pigment epithelium at the
bottom of the panels. The scale
bar represents 50 µm.
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not blue cone opsin. The cone matrix sheaths were very short
and PNA-positive but IRBP labeling was absent (Figure 4D).
The rods were markedly reduced in number in all retinal
regions. The rod OS were shortened and rhodopsin was delo-
calized to the inner segments, cell bodies and synapses. Rod
arrestin was localized to the rod OS, inner segments and cell
bodies. Mitochondria in the rod and cone inner segments were
weakly labeled with anti-cytochrome C oxidase (Figure 4E).
GFAP was increased in the hypertrophied Müller cell processes
(Figure 4F).
Glycine-106-Arginine RHO Mutation (FFB-517): Reti-
nal samples were taken from the nasal and temporal far pe-
riphery and the macula. Like FFB-424 (Q-64-ter), this retina
had advanced disease, and only 1-3 layers of cones and rods
with very short outer segments were present in the peripheral
regions examined. All remaining cones, identified by DIC
microscopy, were well labeled with 7G6 (Figure 5A,B) anti-
X-arrestin, anti-calbindin, and anti-recoverin. The short cone
OS were positive for peripherin-2, and red/green (Figure 5C,D)
but not blue cone opsin. The cone matrix sheaths were very
short and weakly PNA-positive but IRBP labeling was ab-
sent. The macula of this retina showed geographic atrophy
and choroidal neovascularization, and was not used in the
present study.
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Figure 5. Immunocytochem-
istry of retina with G-106-R
RHO mutation.  A. All re-
maining cones are strongly
positive with 7G6. Their
outer segments are short to
absent. B. The cones (arrow-
heads) are documented by
DIC microscopy in the same
field shown in Figure 5A. C.
The shortened cone outer
segments are positive for red/
green cone opsin (gold). The
cone cytoplasm is 7G6-posi-
tive (red). D. Nomarski im-
age of field in Figure 5C il-
lustrates the cones (arrow-
heads). E. As revealed by
anti-rhodopsin labeling, the
rods have tiny or absent outer
segments and rhodopsin (red)
is localized to the cell bodies
(r) and neurites. F. Hypertro-
phied Müller processes are
strongly positive for GFAP
(green), and the few remain-
ing cones (arrowheads) are
well labeled with 7G6 (red).
Autofluorescent lipofuscin is
present in the retinal pigment
epithelium at the bottom of
the panels. The scale bar rep-
resents 50 µm.
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Rods in this retina had tiny or absent OS and rhodopsin
was delocalized to their cell bodies and extensive neurites that
projected into the inner retina (Figure 5E). The few remaining
rod OS were peripherin-2-positive. Most rod inner segments
and cell bodies were weakly labeled with anti-arrestin. All
remaining rods were strongly recoverin-positive. The rod and
cone inner segments were shortened and were not reactive for
cytochrome C oxidase. Hypertrophied Müller cell processes
were strongly reactive for GFAP (Figure 5F).
DISCUSSION
During development of the primate retina, the structural pro-
teins of cone outer segments, the cone opsins and peripherin-
2, are expressed before the cytoplasmic proteins [22-24]. Spe-
cifically, blue cone opsin is expressed before red/green cone
opsin, and the cone visual transduction proteins (alpha-
transducin, phosphodiesterase and rhodopsin kinase) are ex-
pressed even later [22]. Although the function of 7G6 is not
known, this cytoplasmic protein is also expressed after the
opsins in some human cones [25; Personal communication, P.
K. Swain]. In the RP retinas evaluated in this study, it appears
that cones have reversed the sequence of normal development
and regressed to a more primitive state, retaining OS struc-
tural proteins but lacking their specialized cytoplasmic pro-
teins. As these cone cells are stressed and possibly dysfunc-
tional in response to loss or dysfunction of neighboring rods,
they may down regulate expression of the proteins that char-
acterize their differentiated state and retain only their struc-
tural proteins. It is also possible that cones degrade cytoplas-
mic proteins as an early step in apoptosis. Little is known about
the rate of turnover of normal cone OS structural proteins, the
opsins and peripherin-2 [26,27]. This process may be very
slow and require relatively little energy expenditure by the
dedifferentiated cones to maintain their diminutive OS. Pro-
tein turnover experiments in cones of animal models for hu-
man RP would help to elucidate this process.
The loss of cone immunoreactivity is most clearly illus-
trated in the T-17-M RHO retina. The cone OS, although
slightly shortened, showed qualitatively normal labeling with
anti-peripherin-2 and anti-red/green cone opsin. However, re-
activity for several cytoplasmic proteins was decreased in many
of the otherwise normal appearing cones surrounded by T-17-
M mutant rods. It should be noted that although these cones
appeared normal at the level of DIC microscopy, further stud-
ies to assess the cone cytology are needed using electron mi-
croscopy.
In a given area, the same cones showed loss of labeling
with 7G6, anti-X-arrestin, anti-calbindin, and anti-recoverin.
Very similar observations were made on cones surrounded by
mutant rods with shortened OS in rhodopsin-transgenic pigs
[28]. The present results may also correlate with the physi-
ologic demonstration of cone dysfunction spatially following
the expanding “front” of rod dysfunction in autosomal domi-
nant RP due to Class B1 RHO mutations, which include T-17-
M [10].  Loss of immunoreactivity for cytoplasmic proteins
in cones may correspond to the time when neighboring rods
are losing up to 75% of their OS. Consistent with relatively
normal morphology of these cones, cone dysfunction is not
detectable until there is greater than 75% loss of rod OS [10].
In advanced disease with severe loss of rods, as seen in
the Q-64-ter and G-106-R retinas, the few remaining cones
showed strong reactivity for all cytoplasmic proteins exam-
ined. It is possible that the cones lacking cytoplasmic proteins
had died but that these cones survived because they still ex-
pressed these proteins, although this argument is somewhat
circular. Little is known about the control of expression of
photoreceptor proteins, but this observation offers a clue that
not all cones depend on adjacent rods for their survival. In the
RP retinas, the maculas usually show loss of nearly all rods
and many of the cones, with reduction of the remaining cones
to a monolayer of cells with wide cell bodies and tiny or ab-
sent outer segments [1]. These cones can provide reasonably
good visual acuity [29] and closely resemble those in the macu-
las of newborn human infants [30], again suggesting that the
RP disease progress results in regressed differentiation of the
cones.
Several lines of evidence indicate that death of mutant
photoreceptor cells can be delayed by treatment with various
growth/survival factors [15,31], some of which are intrinsic
to human retina [32]. However, the mechanism(s) of rescue
are not known and there is evidence that some neurotrophic
factors activate signaling pathways in Müller cells and other
cells of the inner retina, but not in photoreceptors themselves
[33,34]. The relationship between Müller cells and cones in
degenerate retinas is not well understood, although a recent
study demonstrated that hyperplastic Müller processes are pref-
erentially associated with cones in experimentally detached
cat retinas [35]. Interestingly, in the present study Müller cell
processes had accumulated GFAP in areas where cone cells
showed loss of cytoplasmic protein reactivity and ectopic nu-
clei, although cytologically these cones were otherwise unre-
markable.
Cytochrome C oxidase was decreased in the inner seg-
ments of cones in the severely degenerate retinas with the Q-
64-ter and G-106-R RHOmutations. A similar reduction in cy-
tochrome C oxidase was noted in the inner segments of pho-
toreceptors in detached cat retinas [36]. Maintaining the cats
in hyperoxia prevented the loss of cytochrome C oxidase im-
munoreactivity in the photoreceptors [36]. It is not known if
similar loss of cytochrome C oxidase occurs in animal models
of RP, as observed here in the human RP retinas, or if supple-
mental oxygen would prevent or reverse this pathologic
change.
We found that the mutant rods showed a different pattern
of immunolabeling with anti-arrestin than the controls. As
noted previously in light adapted bovine retinas [37], in the
normal human retinas the labeling with anti-arrestin was most
intense in the OS, with weaker labeling in the cell bodies and
synapses. In the RP retinas examined here (Figure 2K, for ex-
ample), labeling with anti-arrestin was strong in the rod cell
bodies and synapses as well as the OS, more closely resem-
bling the pattern found in dark adapted rods. These observa-
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tions need to be extended to additional RP retinas, but would
appear to be inconsistent with the equivalent-light hypothesis
for rod cell degeneration in RP [38].
Although this study documented loss of immunoreactiv-
ity for cytoplasmic proteins and did not measure mRNA lev-
els, the results are consistent with down regulated expression
of these proteins. If this is the case, the results suggest that
protein renewal has been markedly reduced in cones in re-
sponse to mutant rod cell dysfunction or death. Decreased pro-
tein renewal is also consistent with the severe OS shortening
observed in the surviving cones. Other studies have suggested
that normal rods have a trophic influence on neighboring cones
[16-18], but the putative survival agent has not yet been iden-
tified. As noted previously [20], IRBP immunoreactivity was
decreased in all four RP examined in the present study, sug-
gesting that loss of this rod-derived protein might lead to cone
OS shortening and final cone cell death.
Results from the present study suggest that loss of an un-
known rod factor leads to decreased protein synthesis and,
finally, to degeneration of the neighboring cones. However,
we found loss of cytoplasmic protein reactivity in otherwise
normal appearing cones surrounded by mutant but also nor-
mal appearing rods with shortened OS in the T-17-M RHO
mutant retina. This suggests that a putative down regulation
of cone protein expression is a response to loss of relatively
few rod cells, not an end result of massive rod cell death. If
this is true, initial rod cell death may affect neighboring cones
in a dominant manner, rather than by simply reducing the pu-
tative trophic factor derived from rods. This could be second-
ary to the release of a toxic factor or from reduced input by
rods into the neural network that interconnects rods and cones
in the outer plexiform layer. It is important to obtain further
information on this mechanism, as cones are critical cells es-
sential for daytime vision in the RP patients.
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